Skip to main navigation Skip to search Skip to main content

Thiazolodinediones and Cancer: Duplicate Publication Bias?

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

A meta-analysis of epidemiological studies reported no increased risk for cancer in users of thiazolidinediones; however, subanalyses showed a small 1.1- to 1.2-fold increased risk for bladder cancer with thiazolidinedione use. This analysis was probably distorted by “duplicate publication bias.”
Original languageEnglish
Article number1147
Number of pages1
JournalOncologist
Volume18
Issue number10
DOIs
Publication statusPublished - Oct 2013

Keywords

  • BLADDER-CANCER
  • METAANALYSIS
  • RISK
  • PIOGLITAZONE

Fingerprint

Dive into the research topics of 'Thiazolodinediones and Cancer: Duplicate Publication Bias?'. Together they form a unique fingerprint.

Cite this